A detailed history of Bristlecone Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Bristlecone Advisors, LLC holds 116,556 shares of PFE stock, worth $3.07 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
116,556
Previous 91,275 27.7%
Holding current value
$3.07 Million
Previous $2.55 Million 32.12%
% of portfolio
0.27%
Previous 0.22%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$27.7 - $31.39 $700,283 - $793,570
25,281 Added 27.7%
116,556 $3.37 Million
Q2 2024

Jul 25, 2024

BUY
$25.26 - $29.6 $571,810 - $670,055
22,637 Added 32.98%
91,275 $2.55 Million
Q1 2024

Apr 22, 2024

BUY
$25.89 - $29.73 $1.5 Million - $1.73 Million
58,092 Added 550.84%
68,638 $1.9 Million
Q4 2023

Jan 25, 2024

SELL
$26.13 - $33.94 $757 - $984
-29 Reduced 0.27%
10,546 $303,000
Q3 2023

Oct 16, 2023

BUY
$32.09 - $37.51 $962 - $1,125
30 Added 0.28%
10,575 $350,000
Q2 2023

Aug 03, 2023

BUY
$36.12 - $41.79 $18,457 - $21,354
511 Added 5.09%
10,545 $386,000
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $38,129 - $49,639
-968 Reduced 8.8%
10,034 $409,000
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $14,236 - $18,584
341 Added 3.2%
11,002 $563,000
Q3 2022

Oct 27, 2022

BUY
$43.76 - $53.42 $14,046 - $17,147
321 Added 3.1%
10,661 $467,000
Q2 2022

Jul 25, 2022

SELL
$46.53 - $55.17 $1,721 - $2,041
-37 Reduced 0.36%
10,340 $542,000
Q1 2022

Apr 22, 2022

BUY
$45.75 - $56.69 $1,647 - $2,040
36 Added 0.35%
10,377 $537,000
Q4 2021

Jan 19, 2022

BUY
$41.32 - $61.25 $3,842 - $5,696
93 Added 0.91%
10,341 $611,000
Q3 2021

Oct 19, 2021

SELL
$39.25 - $50.42 $19,389 - $24,907
-494 Reduced 4.6%
10,248 $441,000
Q2 2021

Jul 21, 2021

SELL
$35.91 - $40.68 $1,687 - $1,911
-47 Reduced 0.44%
10,742 $421,000
Q1 2021

Apr 30, 2021

SELL
$33.49 - $37.77 $59,980 - $67,646
-1,791 Reduced 14.24%
10,789 $391,000
Q4 2020

Jan 25, 2021

BUY
$33.47 - $42.56 $3,982 - $5,064
119 Added 0.95%
12,580 $463,000
Q3 2020

Oct 20, 2020

BUY
$31.75 - $37.25 $38,608 - $45,296
1,216 Added 10.81%
12,461 $457,000
Q2 2020

Jul 16, 2020

SELL
$30.12 - $36.54 $50,059 - $60,729
-1,662 Reduced 12.88%
11,245 $368,000
Q1 2020

Apr 16, 2020

SELL
$27.03 - $38.62 $486,540 - $695,160
-18,000 Reduced 58.24%
12,907 $421,000
Q4 2019

Jan 21, 2020

BUY
$32.92 - $37.36 $584,626 - $663,476
17,759 Added 135.07%
30,907 $1.21 Million
Q3 2019

Oct 28, 2019

SELL
$32.49 - $42.13 $593,592 - $769,715
-18,270 Reduced 58.15%
13,148 $472,000
Q2 2019

Jul 19, 2019

BUY
$36.98 - $41.52 $658,909 - $739,803
17,818 Added 131.01%
31,418 $1.36 Million
Q1 2019

Apr 23, 2019

BUY
$37.5 - $41.2 $103,012 - $113,176
2,747 Added 25.31%
13,600 $578,000
Q4 2018

Jan 15, 2019

BUY
$38.47 - $43.86 $2,346 - $2,675
61 Added 0.57%
10,853 $474,000
Q3 2018

Oct 22, 2018

BUY
$34.47 - $41.81 $169,730 - $205,872
4,924 Added 83.91%
10,792 $476,000
Q2 2018

Jul 31, 2018

SELL
$32.98 - $35.16 $52,570 - $56,045
-1,594 Reduced 21.36%
5,868 $213,000
Q1 2018

Apr 24, 2018

SELL
$31.91 - $37.02 $112,546 - $130,569
-3,527 Reduced 32.1%
7,462 $265,000
Q4 2017

Jan 30, 2018

BUY
$33.26 - $35.29 $5,255 - $5,575
158 Added 1.46%
10,989 $398,000
Q3 2017

Oct 20, 2017

BUY
$31.0 - $34.15 $335,761 - $369,878
10,831
10,831 $387,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bristlecone Advisors, LLC Portfolio

Follow Bristlecone Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bristlecone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bristlecone Advisors, LLC with notifications on news.